Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Tables)

v3.23.1
Other current assets (Tables)
3 Months Ended
Mar. 31, 2023
Other current assets  
Summary of other current assets

Other current assets consisted of the following (in thousands):

March 31, 

December 31, 

    

2023

    

2022

Research and development credits receivable

 

$

36,363

$

30,162

Prepayments

 

6,787

9,472

Clinical materials

 

1,310

1,279

VAT receivable

355

490

Other current assets

 

1,664

1,927

$

46,479

$

43,330